El tizón tardío de la patata, introducido por el patógeno oomiceto Phytophthorainfestans, dificulta considerablemente la producción de patatas. Recientemente, se clonó un nuevo gen modelo de resistencia a Phytophthorainfestans (Rpi), Rpi-amr1, a partir de una especie silvestre de Solanum, Solanumamericanum.
Rat Cholesterol ELISA ELISA |
E01A11128 |
BlueGene |
Goat Cholesterol ELISA ELISA |
E01A46041 |
BlueGene |
Mouse Cholesterol ELISA ELISA |
E01A19869 |
BlueGene |
Human Cholesterol ELISA ELISA |
E01A2368 |
BlueGene |
Sheep Cholesterol ELISA ELISA |
E01A98335 |
BlueGene |
La identificación de los correspondientes genes efectores reconocidos (Avirulence o Avr) de P. infestans es crucial para dilucidar su variación de secuencia natural, que a su vez informa de la robustez potencial de la resistencia al tizón tardío afín. Para determinar el efector de P. infestans reconocido por Rpi-amr1, examinamos las bibliotecas de efectores RXLR disponibles y utilizamos un estudio prolongado y la secuenciación de enriquecimiento de patógenos de ADNc (PenSeq) en cuatro aislados de P. infestans para encontrar los efectores no probados.
Utilizando la secuenciación en tiempo real de una sola molécula (SMRT) y PenSeq de ADNc, reconocimos 47 efectores extraordinariamente expresados de P. infestans, junto con PITG_07569, que desencadena una respuesta de falta de vida celular extraordinariamente explícita cuando se coexpresa transitoriamente con Rpi-amr1 en Nicotianabenthamiana, lo que sugiere que PITG_07569 es Avramr1. Aquí mismo mostramos que el estudio prolongado y cDNA PenSeq permite la identificación de los hogares efectores RXLR de longitud completa y su perfil de expresión. Esta mirada ha revelado conocimientos clave en la evolución y el polimorfismo de una familia efector RXLR florido que se asocia con el reconocimiento por Rpi-amr1.
Orf Virus VEGF-E |
MBS691891-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1275 |
Orf Virus VEGF-E |
MBS691947-0002mg |
MyBiosource |
0.002mg |
EUR 265 |
Orf Virus VEGF-E |
MBS691947-5x0002mg |
MyBiosource |
5x0.002mg |
EUR 890 |
VEGF E (Orf Virus) |
cyt-263 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
Orf Virus VEGF-E, Heparin-binding |
MBS691480-002mg |
MyBiosource |
0.02mg |
EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
MBS691480-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
MBS691994-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
MBS691994-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1050 |
Orf virus VEGF-E Recombinant Protein |
300-044 |
ReliaTech |
5 µg |
EUR 136.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-044S |
ReliaTech |
2 µg |
EUR 73.5 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-045 |
ReliaTech |
20 µg |
EUR 357 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Anti-Orf Virus VEGF-E Antibody |
102-PA70 |
ReliaTech |
50 µg |
EUR 115.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
QP10912-1mg |
EnQuireBio |
1mg |
EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 250 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
ov-VEGF-E (Orf virus) (Recombinant) Human |
GWB-C8AD60 |
GenWay Biotech |
0.005 mg |
Ask for price |
VEGFE protein (Orf virus) |
30R-AV011 |
Fitzgerald |
5 ug |
EUR 381 |
|
Description: Purified recombinant VEGFE protein (Orf virus) |
VEGFE protein (Orf virus) |
MBS538323-0005mg |
MyBiosource |
0.005mg |
EUR 505 |
VEGFE protein (Orf virus) |
MBS538323-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 2125 |
Recombinant Orf Virus VEGFE Protein |
VAng-Lsx0417-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Cytochalasin E |
C197-1MG |
TOKU-E |
1 mg |
EUR 79.77 |
|
Description: 36011-19-5 |
Cytochalasin E |
C197-5MG |
TOKU-E |
5 mg |
EUR 276.58 |
|
Description: 36011-19-5 |
Berkeleylactone E |
B087-1MG |
TOKU-E |
1 mg |
EUR 145.66 |
|
Description: 122211-62-5 |
Berkeleylactone E |
B087-5MG |
TOKU-E |
5 mg |
EUR 509.81 |
|
Description: 122211-62-5 |
Chevalone E |
C257-0.5MG |
TOKU-E |
0.5 mg |
EUR 153.46 |
|
Description: 1315451-94-5 |
Chevalone E |
C257-2.5MG |
TOKU-E |
2.5 mg |
EUR 536.69 |
|
Description: 1315451-94-5 |
Deoxybrevianamide E |
D083-1MG |
TOKU-E |
1 mg |
EUR 191.61 |
|
Description: 34610-68-9 |
Deoxybrevianamide E |
D083-5MG |
TOKU-E |
5 mg |
EUR 670.21 |
|
Description: 34610-68-9 |
Oligomycin E |
O021-1MG |
TOKU-E |
1 mg |
EUR 212.42 |
|
Description: 110231-34-0 |
Oligomycin E |
O021-5MG |
TOKU-E |
5 mg |
EUR 741.31 |
|
Description: 110231-34-0 |
Paraherquamide E |
P070-0.5MG |
TOKU-E |
0.5 mg |
EUR 271.38 |
|
Description: 125600-53-5 |
Paraherquamide E |
P070-2.5MG |
TOKU-E |
2.5 mg |
EUR 947.66 |
|
Description: 125600-53-5 |
Phenelfamycin E |
P078-1MG |
TOKU-E |
1 mg |
EUR 212.42 |
|
Description: 114451-31-9 |
Phenelfamycin E |
P078-5MG |
TOKU-E |
5 mg |
EUR 741.31 |
|
Description: 114451-31-9 |
Roquefortine E |
R035-1MG |
TOKU-E |
1 mg |
EUR 150 |
|
Description: 871982-52-4 |
Roquefortine E |
R035-5MG |
TOKU-E |
5 mg |
EUR 524.55 |
|
Description: 871982-52-4 |
Azithromycin impurity E EvoPure® |
A074-5MG |
TOKU-E |
5 mg |
EUR 605.18 |
|
Description: 612069-27-9 |
Hepatitis E virus ORF 3 Recombinant Protein |
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-10mg |
Abbexa |
10 mg |
EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-25mg |
Abbexa |
25 mg |
EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-5mg |
Abbexa |
5 mg |
EUR 225 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
MBS1007472-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
MBS1007472-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
MBS1007472-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
MBS1007472-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
MBS1007472-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 870 |
Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant) |
22060748-1 |
Glycomatrix |
2 µg |
EUR 146.42 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01759 |
CHI Scientific |
2µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01760 |
CHI Scientific |
10µg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
7-01761 |
CHI Scientific |
1mg |
Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
cyt-263-10g |
ProSpec Tany |
10µg |
EUR 145 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
cyt-263-1mg |
ProSpec Tany |
1mg |
EUR 5100 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
cyt-263-2g |
ProSpec Tany |
2µg |
EUR 60 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
MBS142140-0002mg |
MyBiosource |
0.002mg |
EUR 240 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
MBS142140-001mg |
MyBiosource |
0.01mg |
EUR 310 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
MBS142140-1mg |
MyBiosource |
1mg |
EUR 5325 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
MBS142140-5x1mg |
MyBiosource |
5x1mg |
EUR 23640 |
Vascular Endothelial Growth Factor-E Recombinant (Orf Virus) |
rAP-2496 |
Angio Proteomie |
Inquiry |
Ask for price |
Hepatitis E Virus ORF3 Protein |
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF3 Protein |
abx260138-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF3 Protein |
abx260138-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E virus |
8942 |
Virostat |
100 ug |
EUR 340 |
Description: ORF 2 |
Hepatitis E virus |
8943 |
Virostat |
100 ug |
EUR 340 |
Description: ORF 2 |
Hepatitis E virus |
8944 |
Virostat |
100 ug |
EUR 340 |
Description: ORF 3 |
Hepatitis E virus |
MBS328020-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
MBS328020-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
MBS328021-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
MBS328021-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
MBS328022-01mg |
MyBiosource |
0.1mg |
EUR 435 |
Hepatitis E virus |
MBS328022-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1865 |
Hepatitis E virus |
Oneq-H498-OneqH498100R |
Bioingentech |
Oneq-H498-100R |
EUR 1028 |
Hepatitis E virus |
Oneq-H498-OneqH498150R |
Bioingentech |
Oneq-H498-150R |
EUR 1438 |
Hepatitis E virus |
Oneq-H498-OneqH49850R |
Bioingentech |
Oneq-H498-50R |
EUR 728 |
Hepatitis E virus |
PCR-H498-PCRH49848R |
Bioingentech |
PCR-H498-48R |
EUR 485 |
Hepatitis E virus |
PCR-H498-PCRH49896R |
Bioingentech |
PCR-H498-96R |
EUR 685 |
Hepatitis E Virus ORF3 (Recombinant) |
22060181-1 |
Glycomatrix |
100 µg |
EUR 264.47 |
Recombinant Hepatitis E Virus ORF3 |
7-07450 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
7-07451 |
CHI Scientific |
500µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
7-07452 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant Hepatitis E Virus ORF3 |
MBS142588-01mg |
MyBiosource |
0.1mg |
EUR 330 |
Recombinant Hepatitis E Virus ORF3 |
MBS142588-05mg |
MyBiosource |
0.5mg |
EUR 825 |
Recombinant Hepatitis E Virus ORF3 |
MBS142588-1mg |
MyBiosource |
1mg |
EUR 1515 |
Recombinant Hepatitis E Virus ORF3 |
MBS142588-5x1mg |
MyBiosource |
5x1mg |
EUR 6485 |
Hepatitis E Virus ORF3 Recombinant |
rAP-5321 |
Angio Proteomie |
Inquiry |
Ask for price |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
MBS636730-01mg |
MyBiosource |
0.1mg |
EUR 735 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
MBS636730-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3155 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
MBS637880-01mg |
MyBiosource |
0.1mg |
EUR 455 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
MBS637880-05mg |
MyBiosource |
0.5mg |
EUR 1025 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
MBS637880-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4470 |
VEGF (165): Human Recombinant E Coli |
GWB-BDEFEF |
GenWay Biotech |
1 mg |
Ask for price |
Hepatitis E Virus ORF2 (452-617) Protein |
20-abx260268 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (633-659) Protein |
20-abx260269 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (403-461) Protein |
20-abx260270 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV372100R |
Bioingentech |
Oneq-V372-100R |
EUR 1028 |
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV372150R |
Bioingentech |
Oneq-V372-150R |
EUR 1438 |
Hepatitis E virus (ratHEV) |
Oneq-V372-OneqV37250R |
Bioingentech |
Oneq-V372-50R |
EUR 728 |
Hepatitis E virus (ratHEV) |
PCR-V372-PCRV37248R |
Bioingentech |
PCR-V372-48R |
EUR 485 |
Hepatitis E virus (ratHEV) |
PCR-V372-PCRV37296R |
Bioingentech |
PCR-V372-96R |
EUR 685 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
MBS1122067-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
MBS1122067-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
MBS1122067-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
MBS1122067-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E) |
MBS1122067-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 870 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
MBS1108353-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1085 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
MBS1108353-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 680 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
MBS1108353-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 840 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
MBS1108353-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 790 |
Recombinant Vaccinia virus Uncharacterized 18.2 kDa protein (A ORF E) |
MBS1108353-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 985 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
MBS1083094-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1005 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
MBS1083094-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 570 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
MBS1083094-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 755 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
MBS1083094-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 680 |
Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E) |
MBS1083094-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 885 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
MBS1091262-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1040 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
MBS1091262-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 615 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
MBS1091262-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 790 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
MBS1091262-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 715 |
Recombinant Vaccinia virus Uncharacterized 12.9 kDa protein (E ORF F) |
MBS1091262-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 925 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1177237-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1015 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1177237-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 585 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1177237-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 770 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1177237-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 700 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1177237-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 900 |
Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E) |
MBS1229686-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1015 |
Uridina difosfo-glucuronosiltransferasa 1A1, 2A1, 2B4, 2B31:
El deltacoronavirus porcino (PDCoV) es un nuevo coronavirus enteropatógeno que requiere más investigación. En este examen, se extrajo una presión de PDCoV en lengua china, designada CHN-HN-1601, de las heces de un lechón diarreico. Tras la purificación de la placa, se decidió que el genoma compartía entre el 97,5% y el 99,5% de identidades nucleotídicas con 71 cepas de PDCoV consultadas disponibles en el GenBank. Las propiedades patógenas del CHN-HN-1601 se evaluaron utilizando lechones de 5 días.
Todos los lechones inoculados desarrollaron una diarrea extrema a partir de los 2 días post-infección (dpi). Para nuestra sorpresa, se han observado dos intervalos de diarrea que van de 2 a 7 dpi y de 13 a 19 dpi en los lechones afectados en el curso del experimento. La excreción viral fecal de los lechones inoculados se detectó mediante RT-PCR en tiempo real, con un pico de excreción viral a los 4 y 16 dpi, respectivamente. En la necropsia realizada a los 5 dpi, las lesiones macroscópicas primarias incluían intestinos claros, de paredes finas y con distensión gaseosa que contenían un contenido acuoso amarillo.
Otros exámenes histopatológicos, junto con la tinción con hematoxilina y eosina, la inmunohistoquímica y la hibridación in situ con ARN, revelaron que la infección por el virus provocó una atrofia extrema de las vellosidades del intestino delgado, y que el antígeno y el ARN del PDCoV se distribuían principalmente en el citoplasma de las células epiteliales de las vellosidades del yeyuno y el íleon de los lechones.
La fabricación dinámica de IgG específicas del PDCoV y de anticuerpos neutralizantes en el suero de los lechones afectados se evaluó además utilizando un ELISA basado en el virus completo y un ensayo de neutralización basado en la inmunofluorescencia, respectivamente. Además, se construyó un clon infeccioso de ADNc de longitud completa de CHN-HN-1601 utilizando un sistema de cromosoma sintético bacteriano.
El virus rescatado mostró progreso in vitro y propiedades patógenas al igual que el virus parental. En conjunto, nuestro examen no sólo enriquece el conocimiento de PDCoV, sino que además ofrece una plataforma de genética inversa útil para la exploración adicional de la patogénesis del virus.
metabolismo
Objetivo: Las uridina difosfo-glucuronosiltransferasas (UGT) son enzimas unidas a la membrana que catalizan la conjugación del ácido glucurónico en un conjunto variado de xenobióticos. Los caballos glucuronidan con éxito y de forma extensiva numerosos xenobióticos, junto con los opioides, lo que convierte a las UGT en un grupo muy importante de enzimas metabolizadoras de fármacos para la eliminación del remedio. Las enzimas recombinantes han permitido a los investigadores caracterizar el metabolismo de una variedad de remedios. El objetivo principal era clonar, particularizar y caracterizar las UGT equinas utilizando remedios caracterizados como sustratos de UGT en varias especies. Un objetivo secundario era caracterizar el metabolismo in vitro de la morfina en los caballos.
Protein-Export Protein SecB (SecB) Protein |
Abbexa |
Protein-Export Protein SecB (SecB) Protein |
Abbexa |
Protein-Export Protein SecB (SecB) Protein |
Abbexa |
Animales: Microsomas hepáticos y ARN de tejidos recogidos de dos yeguas de pura sangre a las que se les practicó la eutanasia por diversas causas.
Métodos: Basándose totalmente en la homología con el UGT2B7 humano, se han expresado cuatro variantes de UGT equinas: UGT1A1, UGT2A1, UGT2B31 y UGT2B4. Se han clonado secuencias de cDNA y se ha expresado la proteína resultante en un sistema de expresión de baculovirus. La eficacia de las enzimas se evaluó utilizando 4-metilumbeliferona, testosterona, diclofenaco y ketoprofeno. A continuación se han incubado con morfina la enzima recombinante, las células de administración, los microsomas de hígado equino y los supersomas UGT2B7 humanos. Las concentraciones de los metabolitos se han medido mediante cromatografía líquida-espectrometría de masas en tándem y se ha determinado la cinética de la enzima.
Resultados: La 4-metilumbeliferona fue glucuronizada por todas las UGTs equinas expresadas. El glucurónido de testosterona no fue producido por ninguna de las enzimas expresadas, y el glucurónido de diclofenaco y el glucurónido de ketoprofeno fueron producidos por UG2A1 y UGT1A1, respectivamente. El UGT2B31 metabolizó la morfina en morfina-3-glucurónido y en bajas concentraciones de morfina-6-glucurónido.
Conclusiones y relevancia científica: Es la mayor expresión de valor de los UGTs recombinantes equinos útiles. El UGT2B31 contribuye a la glucuronidación de la morfina; sin embargo, es muy probable que no sea la primera enzima metabolizadora. Estos resultados justifican una mayor investigación de los UGTs equinos, junto con la expresión de enzimas adicionales y la caracterización adicional de UGT2B31 como contribuyente al metabolismo de la morfina.
DNA |
MBS6507400-005mg |
MyBiosource |
DNA |
MBS6507400-5x005mg |
MyBiosource |
4-Amino Biphenyl DNA (4-AMBP DNA, 4-Aminobiphenyl DNA) |
MBS600356-01mL |
MyBiosource |
4-Amino Biphenyl DNA (4-AMBP DNA, 4-Aminobiphenyl DNA) |
MBS600356-5x01mL |
MyBiosource |
T4 DNA Ligase (T4 DNA) Enzyme |
abx073011-25g |
Abbexa |
Un genosensor progresivo para la monitorización de la secuencia de Leishmaniaspp utilizando la unión del pDNA al cDNA basado totalmente en Cit-AgNPs
La leishmaniasis está considerada básicamente como una de las enfermedades más importantes con tendencia epidémica, según el World Nicely Being Group. El diagnóstico y el tratamiento tempranos de la infección por Leishmania es un problema eficaz, ya que no presenta síntomas y es resistente al tratamiento. Por lo tanto, hay una necesidad urgente de una detección delicada y precisa de este patógeno.
En este aspecto, un modelo nuevo enfoque fue desarrollado para biosensores ópticos de la secuencia de Leishmaniaspp basado totalmente en la hibridación de Citrato tapado Ag nanopartículas unidas a la sonda explícita de ADN de una sola hebra de Leishmania spp. La agregación del Citrato tapado Ag nanopartículas dentro de la existencia o la falta de una secuencia de ADNc de Leishmania, puso en marcha llamativo y considerable muy importante alterar dentro de la UV-vis.
La baja prohibición de cuantificación (LLOQ) obtenida se logró como 1ZM. Basado totalmente en los extremos experimentales en condiciones óptimas, se llevó a cabo un rápido bioanálisis de la secuencia de Leishmaniaspp (2 min). Por lo tanto, esta sonda puede ser utilizado para la evaluación científica de este patógeno y una enfermedad de la infección.
Mejora de un clon de Cdna infeccioso de tamaño completo del virus de la necrosis interior de las bayas de la vid
El virus de la necrosis interior de las bayas de la vid (GINV) pertenece al género Trichovirus dentro de la familia Betaflexiviridae. El aislado del GINV LN_BETA_RS se obtuvo de una vid “Beta” (Vitis riparia × Vitis labrusca) que presentaba moteado clorótico y mancha anular en Xingcheng, provincia de Liaoning, China. Para confirmar la correlación entre el GINV y la enfermedad del moteado clorótico y la mancha anular de la vid, construimos un clon de ADNc infeccioso del aislado LN_BETA_RS del GINV utilizando la estrategia de reunión sin fisuras.
Utilizando remedios de agroinfiltración el cDNA infeccioso confirmó una infección sistémica de GINV en la Nicotianaoccidentalis 37B mediante la respuesta en cadena de la polimerasa de transcripción inversa (RT-PCR) y la microscopía electrónica de transmisión, exhibiendo signos de moteado clorótico en las hojas. El ADNc infeccioso se transmitió además a nuevos cultivos sanos de N. occidentalis mediante inoculación por frotamiento. Además, el clon de ADNc se agroinfiltró en plántulas de vid “Beta” y “Thompson Seedless”, y las vides inoculadas mostraron moteado clorótico en las hojas y mancha anular en el transcurso de los dos años de declaración.
Las vides “Beta” inoculadas con GINV presentaban un moteado clorótico severo en las hojas y signos de mancha anular en toda la planta, mientras que en las hojas de las vides “Thompson Seedless” agroinoculadas se observaron comparativamente pocos signos a principios de la primavera y sólo apareció progresivamente una débil mancha anular en las primeras hojas jóvenes. Nuestros experimentos cumplieron los postulados de Koch y revelaron la posición causal de GINV en el moteado clorótico de la vid y la enfermedad de la mancha anular.
Una presión deltacoronavirus porcino: caracterización genómica, patogenicidad y su clon infeccioso de ADNc de longitud completa
Beta2-Microglobulin ELISA kit ELISA Kit |
Abfrontier |
Human IL-17E ELISA Kit ELISA kit |
EnoGene |
Human IL-17E ELISA Kit ELISA kit |
EnoGene |
Como nuevo coronavirus enteropatógeno, el deltacoronavirus porcino (PDCoV) merece una investigación adicional. En este examen, se extrajo una presión de PDCoV en lengua china, designada CHN-HN-1601, de las heces de un lechón diarreico. Tras la purificación de la placa, se decidió que el genoma compartía entre el 97,5% y el 99,5% de identidades nucleotídicas con 71 cepas de PDCoV consultadas disponibles en el GenBank.
Las propiedades patógenas del CHN-HN-1601 se evaluaron utilizando lechones de 5 días. Todos los lechones inoculados desarrollaron una diarrea extrema a partir de los 2 días post-infección (dpi). Para nuestra sorpresa, se han observado dos intervalos de diarrea que van de 2 a 7 dpi y de 13 a 19 dpi en los lechones afectados en el curso del experimento. La excreción viral fecal de los lechones inoculados se detectó mediante RT-PCR en tiempo real, con un pico de excreción viral a los 4 y 16 dpi, respectivamente. En la necropsia realizada a los 5 dpi, las lesiones macroscópicas primarias incluían intestinos claros, de paredes finas y con distensión gaseosa que contenían un contenido acuoso amarillo.
Otros exámenes histopatológicos, junto con la tinción con hematoxilina y eosina, la inmunohistoquímica y la hibridación in situ con ARN, revelaron que la infección por el virus provocó una atrofia extrema de las vellosidades del intestino delgado, y que el antígeno y el ARN del PDCoV se distribuían principalmente en el citoplasma de las células epiteliales de las vellosidades del yeyuno y el íleon de los lechones. La fabricación dinámica de IgG específicas del PDCoV y de anticuerpos neutralizantes en el suero de los lechones afectados se evaluó además utilizando un ELISA basado en el virus completo y un ensayo de neutralización basado en la inmunofluorescencia, respectivamente.
Además, se construyó un clon infeccioso de ADNc de longitud completa de CHN-HN-1601 utilizando un sistema de cromosoma sintético bacteriano. El virus rescatado mostró progreso in vitro y propiedades patógenas al igual que el virus parental. En conjunto, nuestro examen no sólo enriquece el conocimiento de PDCoV, sino que además ofrece una plataforma de genética inversa útil para la exploración adicional de la patogénesis del virus.
VEGFE protein (Orf virus) |
MBS538323-0005mg |
MyBiosource |
0.005mg |
EUR 505 |
VEGFE protein (Orf virus) |
MBS538323-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 2125 |
Recombinant Orf Virus VEGFE Protein |
VAng-Lsx0417-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
VAng-Lsx0418-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Orf virus VEGF-E Recombinant Protein |
300-044 |
ReliaTech |
5 µg |
EUR 136.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-044S |
ReliaTech |
2 µg |
EUR 73.5 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
300-045 |
ReliaTech |
20 µg |
EUR 357 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf Virus VEGF-E |
MBS691797-002mg |
MyBiosource |
0.02mg |
EUR 695 |
Orf Virus VEGF-E |
MBS691797-5x002mg |
MyBiosource |
5x0.02mg |
EUR 2830 |
Orf Virus VEGF-E |
MBS691891-0005mg |
MyBiosource |
0.005mg |
EUR 350 |
Orf Virus VEGF-E |
MBS691891-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1275 |
Orf Virus VEGF-E |
MBS691947-0002mg |
MyBiosource |
0.002mg |
EUR 265 |
Orf Virus VEGF-E |
MBS691947-5x0002mg |
MyBiosource |
5x0.002mg |
EUR 890 |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046 |
ReliaTech |
20 µg |
EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
300-046S |
ReliaTech |
5 µg |
EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf Virus VEGF-E, Heparin-binding |
MBS691480-002mg |
MyBiosource |
0.02mg |
EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
MBS691480-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
MBS691994-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
MBS691994-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 1050 |
Anti-Orf Virus VEGF-E Antibody |
102-PA70 |
ReliaTech |
50 µg |
EUR 115.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
PROTQ2F842 |
BosterBio |
Regular: 10ug |
EUR 250 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
QP10912-1mg |
EnQuireBio |
1mg |
EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
QP10912-2ug |
EnQuireBio |
2ug |
EUR 186 |
Human PDGFC / VEGFE, Fc Tag |
E24PHA208 |
EnoGene |
50 μg |
EUR 180 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
QP10912-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Human PDGFC / VEGFE, His Tag |
E24PHA209 |
EnoGene |
50 μg |
EUR 225 |
VEGF E (Orf Virus) |
cyt-263 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
Cynomolgus / Rhesus Macaque PDGFC / VEGFE, Fc Tag |
E24PCA081 |
EnoGene |
50 μg |
EUR 180 |
Cynomolgus / Rhesus Macaque PDGFC / VEGFE, His Tag |
E24PCA082 |
EnoGene |
50 μg |
EUR 225 |
Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics anti-PDGF-C) |
E24CHA317 |
EnoGene |
100 μg |
EUR 225 |
Description: Available in various conjugation types. |
Hepatitis E virus ORF 3 Recombinant Protein |
53-335 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-336 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
53-337 |
ProSci |
0.01 mg |
EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Recombinant Orf virus 10 kDa fusion protein |
MBS1129089-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1015 |
Recombinant Orf virus 10 kDa fusion protein |
MBS1129089-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 580 |
Recombinant Orf virus 10 kDa fusion protein |
MBS1129089-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 765 |
Recombinant Orf virus 10 kDa fusion protein |
MBS1129089-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 695 |
Recombinant Orf virus 10 kDa fusion protein |
MBS1129089-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 895 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038987-002mg |
MyBiosource |
0.02mg |
EUR 1335 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038987-01mg |
MyBiosource |
0.1mg |
EUR 2300 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038987-5x01mg |
MyBiosource |
5x0.1mg |
EUR 10300 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038988-002mg |
MyBiosource |
0.02mg |
EUR 1330 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038988-01mg |
MyBiosource |
0.1mg |
EUR 2295 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS7038988-5x01mg |
MyBiosource |
5x0.1mg |
EUR 10295 |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS1072246-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Orf virus Protein F9 homolog (A3R) |
MBS1202811-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Walleye dermal sarcoma virus ORF-B protein |
MBS7041397-002mg |
MyBiosource |
0.02mg |
EUR 1615 |
Recombinant Walleye dermal sarcoma virus ORF-B protein |
MBS7041397-01mg |
MyBiosource |
0.1mg |
EUR 2570 |
Recombinant Walleye dermal sarcoma virus ORF-B protein |
MBS7041397-5x01mg |
MyBiosource |
5x0.1mg |
EUR 11530 |
Recombinant Orf virus Protein F9 homolog (A3R), partial |
MBS7061474-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Orf virus Protein F9 homolog (A3R), partial |
MBS7061495-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Recombinant Walleye dermal sarcoma virus ORF-B protein, partial |
MBS7091428-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-10mg |
Abbexa |
10 mg |
EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
20-abx263083 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-25mg |
Abbexa |
25 mg |
EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
abx263083-5mg |
Abbexa |
5 mg |
EUR 225 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
MBS1050972-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1200 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
MBS1050972-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 850 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
MBS1050972-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 990 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
MBS1050972-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1020 |
Recombinant Figwort mosaic virus Movement protein (ORF I) |
MBS1050972-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1007636-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1007636-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1007636-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1007636-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1007636-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1092759-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1092759-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1092759-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1092759-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1092759-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1131598-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1131598-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1131598-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1131598-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1131598-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1235484-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1235484-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1235484-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1235484-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1235484-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1250494-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1250494-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1250494-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1250494-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Cauliflower mosaic virus Capsid protein (ORF IV) |
MBS1250494-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
MBS1432961-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1045 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
MBS1432961-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 620 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
MBS1432961-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 795 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
MBS1432961-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 720 |
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) |
MBS1432961-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 930 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1093694-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1093694-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1093694-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1093694-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1093694-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1033786-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1033786-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1033786-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1033786-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1033786-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1184457-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1205 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1184457-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 855 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1184457-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 995 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1184457-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1030 |
Recombinant Cauliflower mosaic virus Movement protein (ORF I) |
MBS1184457-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1130 |
Virus Measles Virus (MeV) Protein |
abx670263-1ml |
Abbexa |
1 ml |
EUR 543.6 |
|
Hepatitis E Virus ORF3 Protein |
20-abx260138 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF3 Protein |
abx260138-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF3 Protein |
abx260138-5g |
Abbexa |
5 µg |
EUR 350 |
Varicella Zoster Virus ORF26 Protein |
20-abx260176 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Varicella Zoster Virus ORF26 Protein |
abx260176-20g |
Abbexa |
20 µg |
EUR 950 |
Varicella Zoster Virus ORF26 Protein |
abx260176-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF 2 Recombinant Protein beta-galactosidase liquid |
IHEPEHEPEORF2R10UG |
Innovative research |
each |
EUR 762 |
|
Description: Hepatitis E Virus ORF 2 Recombinant Protein beta-galactosidase liquid |
Hepatitis E Virus ORF 3 Recombinant Protein beta-galactosidase liquid |
IHEPEHEPEORF3R10UG |
Innovative research |
each |
EUR 762 |
|
Description: Hepatitis E Virus ORF 3 Recombinant Protein beta-galactosidase liquid |
Hepatitis E Virus ORF 2 Recombinant Protein beta-galactosidase liquid |
MBS8431072-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Hepatitis E Virus ORF 3 Recombinant Protein beta-galactosidase liquid |
MBS8431073-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Virus West Nile Virus (WNV) Protein |
abx670276-100ug |
Abbexa |
100 ug |
EUR 794.4 |
|
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
MBS1130671-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1355 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
MBS1130671-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1055 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
MBS1130671-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1125 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
MBS1130671-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1230 |
Recombinant Figwort mosaic virus Probable capsid protein (ORF IV) |
MBS1130671-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1310 |
Varicella Zoster Virus ORF9 Protein |
20-abx260175 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Varicella Zoster Virus ORF9 Protein |
abx260175-20g |
Abbexa |
20 µg |
EUR 950 |
Varicella Zoster Virus ORF9 Protein |
abx260175-5g |
Abbexa |
5 µg |
EUR 350 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
MBS1056689-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1195 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
MBS1056689-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 845 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
MBS1056689-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 985 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
MBS1056689-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1015 |
Recombinant Carnation etched ring virus Movement protein (ORF I) |
MBS1056689-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1125 |
Virus Hepatitis A Virus (HAV) Protein |
abx670259-1ml |
Abbexa |
1 ml |
EUR 427.2 |
|
Virus Yellow Fever Virus (YFV) Protein |
abx670277-100ug |
Abbexa |
100 ug |
EUR 644.4 |
|
Hepatitis E Virus ORF2 (452-617) Protein |
20-abx260268 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-20g |
Abbexa |
20 µg |
EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
abx260268-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (633-659) Protein |
20-abx260269 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
abx260269-5g |
Abbexa |
5 µg |
EUR 350 |
Hepatitis E Virus ORF2 (403-461) Protein |
20-abx260270 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-25g |
Abbexa |
25 µg |
EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
abx260270-5g |
Abbexa |
5 µg |
EUR 350 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
MBS1213579-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1040 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
MBS1213579-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 615 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
MBS1213579-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 790 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
MBS1213579-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 715 |
Recombinant Figwort mosaic virus Virion-associated protein (ORF III) |
MBS1213579-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 925 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
MBS1057844-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1085 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
MBS1057844-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 675 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
MBS1057844-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 840 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
MBS1057844-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 785 |
Recombinant Figwort mosaic virus Aphid transmission protein (ORF II) |
MBS1057844-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 980 |
Virus Varicella Zoster Virus (VZV) Protein |
abx670269-1ml |
Abbexa |
1 ml |
EUR 794.4 |
|
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1013968-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1013968-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1013968-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1013968-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1013968-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1053151-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1053151-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1053151-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1053151-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1053151-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1149572-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1149572-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1149572-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1149572-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1149572-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1261084-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1261084-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 630 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1261084-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1261084-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III) |
MBS1261084-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1029118-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1029118-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1029118-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1029118-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1029118-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1125301-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1125301-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1125301-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1125301-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 780 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1125301-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 975 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1161869-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1080 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1161869-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 670 |
Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II) |
MBS1161869-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 835 |
Fuente :
- Gentaur
- NCBI